Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

Kommoss, Stefan; K. McConechy, Melissa; Kommoss, F.; Leung, Samuel; Bunz, Anne-Kathrin; Magrill, Jamie; Britton, Heidi; Kommoss, F.; Grevenkamp, Friederike; N. Karnezis, Anthony; Yang, Winnie; Lum, Amy; Krämer, B.; Taran, Florin‐Andrei; Staebler, Annette; Lax, S.; Brücker, S; G. Huntsman, David; Blake Gilks, C.; N. McAlpine, Jessica; Talhouk, Aline

doi:10.1093/annonc/mdy058

Public

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

Published in Annals of Oncology • Feb 7, 2018

Authors:

Stefan Kommoss

Melissa K. McConechy

F. Kommoss

Abstract

Background: We have previously developed and confirmed a pragmatic molecular classifier for endometrial cancers; ProMisE (Proactive Molecular Risk Classifier for Endometrial Cancer). Inspired by the Cancer Genome Atlas, ProMisE identifies four prognostically distinct molecular subtypes and can be ap...

Subject

Medicine

Classifier (UML)

Carcinoma

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!